Drug distributors win key federal opioid trial in hard-hit West Virginia county
A federal judge in West Virginia sided with three major U.S. drug distributors on Monday, ruling that the drug companies can't be held responsible for the addiction epidemic in Cabell County after flooding the are with opioids. U.S. District Judge David Faber issued his 184-page ruling nearly a year after lawyers for Cabell County and the drug companies — AmerisourceBergen, Cardinal Health, and McKesson — concluded a three-month bench trial in Faber's court.
The three drug companies distributed 81 million hydrocodone and oxycodone pills to Cabell County over an eight-year period ending in 2014, a quantity that works out to 94 pills for each adult and child every year. Lawyers for the county argued that the drug distributors acted unreasonably, recklessly, and without regard for public health and safety, ignoring red flags that their "tsunami" of pills were being funneled to the black market as the area wrestled with a growing opioid-fueled addiction crisis.
Lawyers for the drug companies countered that they were only fulfilling orders from licensed pharmacies based on prescriptions written by doctors. Judge Faber agreed, writing that while "the opioid crisis has taken a considerable toll on the citizens of Cabell County and the city of Huntington," cases such as this one "must be decided not based on sympathy, but on the facts and the law," and the plaintiffs did not prove the companies violated public nuisance laws or tie the companies' conduct to the harm in the communities.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The use of public nuisance laws in opioid cases has had mixed results across the country, but this was the first one involving opioid distributors to end up at federal trial, The Associated Press reports. "The result could have huge effects on similar lawsuits." The plaintiffs said they are "deeply disappointed" with the ruling and may file an appeal. Drug overdose deaths hit a new nationwide high in 2021, and Cabell County reported significantly higher numbers of emergency responses to suspected overdoses compared with previous years.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Best staycation destinations in Wales
The Week recommends Rich in Celtic culture, coastline and castles, England's neighbouring nation has much to offer visitors
By Adrienne Wyper, The Week UK Published
-
The importance of discussing and dealing with debt
The Explainer Increasing numbers of people have 'problem debt' – but there are ways to tackle it
By Marc Shoffman, The Week UK Published
-
'Trump heavy on retribution, light on cash'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Narcan is becoming harder to find at drugstores across America
Under the Radar The drug, also known as naloxone, reverses the effects of an opioid overdose
By Justin Klawans, The Week US Published
-
The lows of an unregulated high: Teens are using marijuana alternative delta-8
In the Spotlight More than 1 in 10 high school seniors have reported using the substance, which contains concentrated THC
By Justin Klawans, The Week US Published
-
Tianeptine: why lawmakers fear a new kind of opioid
The explainer The drug is sold over the counter. And is highly addictive.
By Devika Rao, The Week US Published
-
The pros and cons of compounding pharmacies
Pros and cons Customizing medications can be lifesaving and also dangerous
By Devika Rao, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
How polysubstance abuse is worsening the American opioid crisis
The Explainer Studies are showing that more Americans are struggling with dependency on multiple substances.
By Theara Coleman, The Week US Published